A carregar...
Publicação
Equity research on GE Healthcare: comprehensive company analysis and assessment of macroeconomic opportunities and risks
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.3 MB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
This report is part of a detailed equity
research analysis on GE HealthCare
(GEHC), a global MedTech leader
specializing in diagnostic imaging. GEHC
operates in a total addressable market
(TAM) of approximately USD 114 billion
in FY24, with growth projections reaching
USD 188 billion by FY32. It begins with an
investment summary, outlining the key
rationale for assigning a buy rating with a
target price of approximately USD 107,
representing a potential upside of +35%
(including an estimated dividend of USD
2.2 in FY25). The section also provides
an overview of GEHC’s company profile
and business segments, highlighting its
strategic innovation initiatives since
becoming a standalone company. It
offers a comprehensive analysis of
GEHC’s historical and current financial
performance. The report further
examines important macroeconomic
factors such as rising global healthcare
spending, improved access to healthcare
in emerging markets, the impact of an
aging global population, and potential
policy shifts under the newly elected U.S.
president that are critical to the forecasts
presented in the joint report.
Descrição
Palavras-chave
Financial analysis Medtech Equity research Macroeconomic trends